< Back to previous page
Researcher
Amuri Kilonda
- Disciplines:Condensed matter physics and nanophysics, Analytical chemistry, Pharmaceutical analysis and quality assurance, Inorganic chemistry, Organic chemistry, Physical chemistry
Affiliations
- Sustainable Chemistry for Metals and Molecules (Division)
Member
From1 Oct 2004 → 31 Dec 2006
Publications
1 - 4 of 4
- Identification of novel FLT3 kinase inhibitors(2013)
Authors: Amuri Kilonda, Patrick Chaltin, Arnaud Marchand, Jan Cools
Pages: 713 - 21 - Evaluation of the in vivo anti-inflammatory activity of a flavonoid glycoside from Boldoa purpurascens(2011)
Authors: Dulce Maria Gonzalez Mosquera, Yannarys Hernandez Ortega, Amuri Kilonda, Wim Dehaen, Luc Pieters, Sandra Apers
Pages: 231 - 234 - Evaluation of the in vivo anti-inflammatory activity of a flavonoid glycoside from Boldoa purpurascens(2011)
Authors: Amuri Kilonda, Wim Dehaen
Pages: 231 - 234 - New flavonoids from Boldoa purpurascens cav(2008)
Authors: Amuri Kilonda, Suzanne Toppet, Frans Compernolle, Wim Dehaen, Isabelle François, Bruno Cammue
Pages: 1468 - 1473
Patents
1 - 10 of 10
- Aryl derivatives for treating trpm3 mediated disorders (Inventor)
- Heterocycle derivatives for treating trpm3 mediated disorders (Inventor)
- Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases (Inventor)
- Compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders (Inventor)
- Compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders (Inventor)
- Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases (Inventor)
- Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases (Inventor)
- N-((1h-indol-3-yl)-alkyl)-4-benzyl)benzamide and n-((1h-pyrrolo[2,3-b]pyridin-3-yl)-alkyl)-4-benzyl)benzamide derivatives as alpha synuclein aggregation inhibitors for the treatment of neurodegenerative disorders (Inventor)
- Compounds for the treatment of neurodegenerative diseases (Inventor)
- N-(2-(5-substituted-1H-indol-3-yl)ethyl)biphenyl-4-carboxamide derivatives and related compounds as Tau-aggregation induced toxicity inhibitors for the treatment of neurodegenerative disorders (Inventor)